Characteristics of orphan drug applications that fail to achieve marketing approval in the USA

H.E. Heemstra; H.G.M. Leufkens; R.P. Rodgers; K. Xu; B.C. Voordouw; M. Braun

Characteristics of orphan drug applications that fail to achieve marketing approval in the USA

H.E. Heemstra, H.G.M. Leufkens, R.P. Rodgers, K. Xu, B.C. Voordouw, M. Braun

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	73-80
Number of pages	8
Journal	Drug Discovery Today
Volume	16
Issue number	1-2
Publication status	Published - 2011

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM)
Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{8643e0aa98224725a64c8aba3150a93a,

title = "Characteristics of orphan drug applications that fail to achieve marketing approval in the USA",

keywords = "Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "H.E. Heemstra and H.G.M. Leufkens and R.P. Rodgers and K. Xu and B.C. Voordouw and M. Braun",

year = "2011",

language = "Undefined/Unknown",

volume = "16",

pages = "73--80",

journal = "Drug Discovery Today",

issn = "1359-6446",

publisher = "Elsevier Ltd",

number = "1-2",

}

TY - JOUR

T1 - Characteristics of orphan drug applications that fail to achieve marketing approval in the USA

AU - Heemstra, H.E.

AU - Leufkens, H.G.M.

AU - Rodgers, R.P.

AU - Xu, K.

AU - Voordouw, B.C.

AU - Braun, M.

PY - 2011

Y1 - 2011

KW - Farmacie/Biofarmaceutische wetenschappen (FARM)

KW - Epidemiology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Ziekenhuisstructuur en organisatie van de gezondheidszorg

KW - Public Health

M3 - Article

SN - 1359-6446

VL - 16

SP - 73

EP - 80

JO - Drug Discovery Today

JF - Drug Discovery Today

IS - 1-2

ER -